BioSpace News Archive

EPIDIOLEX®, the first FDA-approved prescription pharmaceutical formulation of highly purified, plant-derived cannabidiol (CBD), a cannabinoid lacking the high associated with marijuana and the first in a new category of anti-epileptic drugs.

DSUVIA (sufentanil sublingual tablet 30 mcg) is indicated for the management of acute pain severe enough to require an opioid analgesic for adult patients in certified medically supervised healthcare settings

The Personalized Medicine Coalition (PMC) will convene its 14th Annual Personalized Medicine Conference at Harvard Medical School from November 14 – 15, 2018, to address unresolved challenges in health care that FDA Commissioner Scott Gottlieb, M.D., warns may discourage the development of “potentially curative” treatment strategies.

The Government of Canada recognizes that Canadian innovation has helped make our country a leader in producing safe, high quality products and we are committed to fostering innovation in the agricultural sector – here in Canada and beyond.

Quadrant Biosciences announced today that they will support Autism Speaks’ mission with funding to expand delivery of reliable information, resources and support through the Autism Speaks Autism Response Team.

Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced that ten abstracts have been selected for presentation, including three oral presentations, at the upcoming American Society of Hematology (ASH) 2018 Annual Meeting being held December 1-4, 2018 in San Diego.

NuCana plc (NASDAQ: NCNA) announced the first patients have been enrolled in the NuTide:302 Study.

ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company, is pleased to announce the appointment of Dr Jan Groen as a Non-Executive Director of the Company effective 1 November 2018.

Madrona Venture Group awarded the 13th Annual Madrona Prize last night to the EMBARKER team at the University of Washington’s Paul G. Allen School of Computer Science & Engineering.

Emmaus Life Sciences, Inc. announced today that its abstract has been accepted for poster presentation at the American Society of Hematology (ASH) 2018 Annual Meeting taking place in San Diego, California from December 1 - 4.